Africa Daily cover image

Africa Daily

Lenacapavir: could new HIV drug help end the pandemic?

Jul 23, 2024
Exploring the potential of Lenacapavir, a new HIV drug with a 100% success rate, and the challenges of pricing for those in poor countries. Discussing the evolution of HIV treatment, adherence challenges, and the importance of affordable medication. Looking at expanding access to the drug in Africa through advocacy and licensing agreements.
20:25

Podcast summary created with Snipd AI

Quick takeaways

  • Lenacapavir offers hope for affordable and effective HIV treatment.
  • Challenges in pricing and accessibility must be addressed for global impact of new HIV drugs.

Deep dives

Ntimwe Mpamba: Africa's Longest Survivor of HIV

Ntimwe Mpamba, born with HIV 42 years ago, believed to be Africa's longest survivor. He only discovered his condition at 23, having spent three-quarters of his life in hospitals due to the virus. Initially facing a strenuous anti-retroviral regime, advancements led to a one-day tablet, with Ntimwe being a research participant for its introduction. The podcast highlights his journey and the potential impact of new drugs like Lenacapavir on combatting HIV.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode